A trio of top US firms have taken lead roles on the $3.9bn (£2.5bn) private equity takeover of contract drug researcher Pharmaceutical Product Development (PPD), reports The Am Law Daily. The US-based organisation is being acquired by the Carlyle Group and Hellman & Friedman after fielding offers from rival bidders including Blackstone Group and KKR.
October 04, 2011 at 05:34 AM
1 minute read
The original version of this story was published on Legalweek
A line-up of top US firms have taken lead roles on the $3.9bn (£2.5bn) private equity takeover of contract drug researcher Pharmaceutical Product Development (PPD), reports The Am Law Daily.
The US-based organisation is being acquired by the Carlyle Group and Hellman & Friedman after fielding offers from rival bidders including Blackstone Group and KKR.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
